166 related articles for article (PubMed ID: 20302386)
1. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone.
Bowen DA; Call TG; Shanafelt TD; Kay NE; Schwager SM; Reinalda MS; Rabe KG; Slager SL; Zent CS
Leuk Lymphoma; 2010 Apr; 51(4):620-7. PubMed ID: 20302386
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hemorrhagic telangiectasia, idiopathic thrombocytopenic purpura, and chronic lymphocytic leukemia treated with rituximab.
Choueiri T; Lichtin AE
Am J Med; 2002 Dec; 113(8):700-1. PubMed ID: 12505128
[No Abstract] [Full Text] [Related]
3. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
Zent CS; Shanafelt T
Leuk Lymphoma; 2009 Jun; 50(6):863-4. PubMed ID: 19455465
[No Abstract] [Full Text] [Related]
4. Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.
Langerbeins P; Busch R; Anheier N; Dürig J; Bergmann M; Goebeler ME; Hurtz HJ; Stauch MB; Stilgenbauer S; Döhner H; Fink AM; Cramer P; Fischer K; Wendtner CM; Hallek M; Eichhorst B
Am J Hematol; 2014 Dec; 89(12):E239-43. PubMed ID: 25196783
[TBL] [Abstract][Full Text] [Related]
5. Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.
Strati P; Wierda W; Burger J; Ferrajoli A; Tam C; Lerner S; Keating MJ; O'Brien S
Cancer; 2013 Nov; 119(21):3805-11. PubMed ID: 23943357
[TBL] [Abstract][Full Text] [Related]
6. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Schmitt B; Wendtner CM; Bergmann M; Busch R; Franke A; Pasold R; Schlag R; Hopfinger G; Hiddemann W; Emmerich B; Hallek M
Clin Lymphoma; 2002 Jun; 3(1):26-35. PubMed ID: 12141952
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Yoon DH; Yang DH; Lee WS; Kim HJ; Yhim HY; Jeong SH; Won JH; Lee S; Kong JH; Lim SN; Ji JH; Kwon KA; Lee GW; Lee JH; Lee HS; Shin HJ; Suh C
Cancer Commun (Lond); 2019 Oct; 39(1):58. PubMed ID: 31619290
[TBL] [Abstract][Full Text] [Related]
9. A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).
Ferrara F; Del Vecchio L; Mele G; Rametta V; Ronconi F; Montuori R
Cancer; 1989 Aug; 64(4):789-92. PubMed ID: 2743271
[TBL] [Abstract][Full Text] [Related]
10. Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.
Vlachaki E; Tselios K; Charalambidou S; Ioannidou E; Klonizakis I
Int J Hematol; 2008 Oct; 88(3):341-342. PubMed ID: 18766306
[No Abstract] [Full Text] [Related]
11. Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL).
Shanafelt T; Lanasa MC; Call TG; Beaven AW; Leis JF; LaPlant B; Bowen D; Conte M; Jelinek DF; Hanson CA; Kay NE; Zent CS
Cancer; 2013 Nov; 119(21):3788-96. PubMed ID: 23922059
[TBL] [Abstract][Full Text] [Related]
12. Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
Levitt MJ; Gharibo M; Strair R; Schaar D; Rubin A; Bertino JR
J Chemother; 2009 Aug; 21(4):434-8. PubMed ID: 19622463
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.
Wanner D; Bohn JP; Rudzki J; Stockhammer G; Steurer M
Ann Hematol; 2019 Jan; 98(1):205-207. PubMed ID: 29804266
[No Abstract] [Full Text] [Related]
14. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
15. Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.
Kay NE; Geyer SM; Call TG; Shanafelt TD; Zent CS; Jelinek DF; Tschumper R; Bone ND; Dewald GW; Lin TS; Heerema NA; Smith L; Grever MR; Byrd JC
Blood; 2007 Jan; 109(2):405-11. PubMed ID: 17008537
[TBL] [Abstract][Full Text] [Related]
16. Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.
Lamanna N; Kalaycio M; Maslak P; Jurcic JG; Heaney M; Brentjens R; Zelenetz AD; Horgan D; Gencarelli A; Panageas KS; Scheinberg DA; Weiss MA
J Clin Oncol; 2006 Apr; 24(10):1575-81. PubMed ID: 16520464
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
18. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
19. Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study.
Jäeger G; Neumeister P; Brezinschek R; Höfler G; Quehenberger F; Linkesch W; Sill H
Eur J Haematol; 2002 Jul; 69(1):21-6. PubMed ID: 12270058
[TBL] [Abstract][Full Text] [Related]
20. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
